Physician profile
Stacey Copeland
NPI 1861590770
$283.66
in general payments reported to CMS, 2019-2025
10 companies · $16.33 in 2025
The $16.33 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $54.61 · 2023: $23.68 · 2024: $88.13 · 2025: $16.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $54.81 | 2024 | Pico 7 |
| Endomagnetics LTD | $54.61 | 2020 | |
| Tempus Ai, INC | $33.32 | 2024 | |
| Amgen INC. | $28.67 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.03 | 2019 | |
| Innovation Technologies INC | $23.68 | 2023 | Irrisept |
| Regeneron Healthcare Solutions, INC. | $20.38 | 2019 | |
| Davol INC. | $16.33 | 2025 | Phasix Mesh |
| Vifor Pharma, INC. | $15.83 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Copeland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.